Companies: 10,795·Total market cap: $144.5T
USANA Health Sciences, Inc.

USANA Health Sciences, Inc.

USNANYSEConsumer Defensive● Active
$18.70
+$0.67(+3.72%)
Market Cap$345258306
P/E Ratio
52W High$38.32
52W Low$16.6
Overview

USANA Health Sciences, Inc. (USNA) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0000896264 · USNA · NYSE · as of Jun 8, 2026

Filing snapshot

1,000+
Total Filings
4
Latest Form
2026-06-01
Most Recent
1994
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0000896264 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-16
Fiscal Year End
Mar 16, 2026
Accession No.
0000896264-26-000021
Primary Document
usna-20260103.htm
Source: data.sec.gov · CIK 0000896264 · Accession 0000896264-26-000021

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-12
8-KCurrent Report
8-K
2026-05-20Material Event
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-05-20
View
10-QQuarterly Report
10-Q
2026-05-12
View
8-KCurrent Report
8-K
2026-05-05
View
ARSARS
ARS
2026-04-07
View
DEF 14AProxy Statement
DEF 14A
2026-04-07
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-03-30
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-03-27
View
10-KAnnual Report
10-K
2026-03-16
View
8-KCurrent Report
8-K
2026-02-18
View
8-K/ACurrent Report (Amended)
8-K/A
2026-02-11
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-01-21
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-01-21
View
8-KCurrent Report
8-K
2026-01-12
View
8-KCurrent Report
8-K
2026-01-08
View
10-QQuarterly Report
10-Q
2025-11-05
View
Showing 1–15 of 204 filingsForm 4 / 144 hidden· 1000 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0000896264  |  Exchange: NYSE · Consumer Defensive

USANA Health Sciences, Inc. (NYSE: USNA) has submitted 1,000+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1994. As a Consumer Defensive sector company with CIK 0000896264, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is USANA Health Sciences, Inc.'s most comprehensive regulatory disclosure. The most recent USANA Health Sciences, Inc. 10-K was filed on 2026-03-16 for fiscal year ending 2026. Historical USNA 10-K annual reports are available from 2017 through 2026.

Investors researching USANA Health Sciences, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08

Frequently Asked Questions

USNA SEC Filings · 8 questions

USANA Health Sciences, Inc. (USNA) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,000+ filings and access original documents at no cost. USANA Health Sciences, Inc.'s CIK is 0000896264.

USNA SEC filingsUSANA Health Sciences, Inc. SEC documentsfind USNA 10-K